Optimised Dalbavancin Dosing for Serious Gram-Positive Bacterial Infections

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Optimised Dalbavancin Dosing for Serious Gram-Positive Bacterial Infections	Serious Gram-Positive Bacterial Infections	Not yet recruiting	Not stated	2026-10-05		NCT07858526

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Kirby Institute	19

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Prince of Wales Hospital	Sydney	Australia	5
St Vincent's Hospital Sydney	Sydney	Australia	2

Clinical trials